Related Experiment Video
Updated: May 11, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression
Tal Twito1, Zhiqi Chen, Ismat Khatri
1Transplant Research Division, University Health Network, Toronto General Hospital, University of Toronto, Canada.
Insights
ADAM28 enzymes are involved in the shedding of CD200 (a protein overexpressed in chronic lymphocytic leukemia). This shedding releases soluble CD200 (sCD200), a marker of poor prognosis in CLL patients.
Area of Science:
- Immunology
- Biochemistry
- Oncology
Background:
- CD200, a membrane glycoprotein, is overexpressed in chronic lymphocytic leukemia (CLL).
- Soluble CD200 (sCD200) in serum correlates with poor prognosis in CLL.
- ADAM (a disintegrin and metalloproteinase) enzymes are known to mediate membrane protein shedding.
Purpose of the Study:
- To investigate the role of ADAM28 in the shedding of CD200 in CLL.
- To determine the correlation between ADAM28 expression and sCD200 levels in CLL patients.
Main Methods:
- Analysis of ADAM28 mRNA expression in CLL samples.
- Measurement of plasma sCD200 levels.
- In vitro studies using siRNA to inhibit ADAM28 and gene transfection to overexpress ADAM28 in CLL cells.
Main Results:
- ADAM28 mRNA expression in CLL was correlated with plasma sCD200 levels.
- ADAM28 expression correlated with sCD200 release from cultured CLL cells.
- siRNA-mediated knockdown of ADAM28 reduced sCD200 release.
- Transfection of ADAM28 into CD200-expressing cells enhanced sCD200 release.
Conclusions:
- ADAM28 plays a significant role in the shedding of CD200 from B-cell CLL cells.
- ADAM28 may represent a therapeutic target for modulating sCD200 levels in CLL.
Abstract:
CD200, a membrane glycoprotein of the immunoglobulin superfamily, is overexpressed in CLL. Soluble in serum CD200 (sCD200) is correlated with poor prognosis in CLL. ADAM (a disintegrin and metalloproteinase) enzymes are implicated in membrane protein shedding. ADAM28 mRNA expression in CLL was correlated with plasma sCD200 levels, and release into culture from CLL cells. siRNA for ADAM28 decreased release of sCD200 from cultures and transfection of a cloned ADAM28 gene into CD200(+) cells enhanced release of sCD200. Our data support the hypothesis that ADAM28 plays a role in the shedding of CD200 from B-cell CLL cells.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

